Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How to stop a stroke in its tracks

  • Significant increase in major depression reported during recent recession

  • Discovery may open door for treating fragile X carriers

  • Fat tissue controls brain's response to food scarcity, helping regulate optimal amount of body fat for brain function

  • Risk perception: Social exchange can amplify subjective fears

  • Psychology of the appeal of being anti-GMO

  • New light shed on brain's source of power

  • We think better on our feet, literally

  • Inclusive classrooms don't necessarily increase friendships for children with disabilities

  • New insight into how brain makes memories

  •